Professional Documents
Culture Documents
• Provides the criteria that are used to judge the quality of Identification tests
an analysis
• ensure identity of an analyte in a sample
• Control of analytical quality
• normally achieved via comparison of a property of the
• Control of errors in analysis
sample
• Validation of analytical procedures
• Cross-checking and monitoring of procedures, Testing for Impurities
methods and products
• Quantitative test or a limit test
VALIDATION USP 1225 • Accurately reflect the purity characteristics of the
sample
• Is defined as the verification, by data and analysis, that
the design objectives of a given facility, system, Assay
apparatus, or procedures are reliably fulfilled in routine
operation. • Measure the analyte present in a given sample.
• A planned series of interactive tests and inspection ➢ assay represents a quantitative measurement
➢ designed to describe and reduce uncertainty of the major component(s) in the drug
in an important process. substance.
• Validated product
Drug Product - similar validation characteristics
➢ appropriate scientific means to be uniform
within a lot, consistent between lots, and VALIDATION CHARACTERISTICS
meeting design criteria within defined limits.
Specificity
PROCESS VALIDATION
• Ability to assess unequivocally the analyte in the
• A documented program which provides a high degree of presence of components which may be expected to be
assurance that a specific process will consistently present.
produce a product meeting its predetermined
specification and quality attributes. Identification: Ensure the identity of the analyte
• Pharmaceutical process validation consists of well
documented, written procedures that define processes Purity Tests: Accurate statement of the content of impurities of
which ensure that a specific pharmaceutical an analyte
technology is capable of and is attaining that which is Assay: provide an exact result on the content or potency of an
specified in official or inhouse specifications. analyte in the sample
• Prospective or Retrospective
ACCURACY
RETROSPECTIVE VALIDATION
• Expresses the closeness of agreement between the
• Applicable for a product that has been on the market value which is accepted either as a conventional true
➢ adequate data is available for evaluation value or an accepted reference value and the value
• Consists of an evaluation of product characteristics found.
over time ➢ trueness
• Evaluation via control charts • Assessed using a minimum of 9 determinations over a
➢ Each attribute could be charted giving a visual minimum of 3 concentration levels covering the
display of the batch history. specified range.
➢ allows an evaluation of the consistency of the • Reported as percent recovery by the assay of known
process. added amount of analyte in the sample or as the
➢ helpful in identifying problems and as an aid difference between the mean and the accepted true
in setting practical in-house release limits. value together with the confidence intervals.
• Useful evaluative procedure - relatively large number
of batches (long period of time) PRECISION
• Gives detailed information on the product performance.
• Expresses the closeness of agreement (degree of
PROSPECTIVE VALIDATION scatter) between a series of measurements obtained
from multiple sampling of the same homogeneous
• Must ALWAYS be performed for a new product during sample under the prescribed conditions.
initial development and production.
• First three production batches - consistency and 3 LEVELS OF PRECISION
accuracy
• Attributes measured reflect the important or critical REPEATABILITY (intra-assay):
characteristics of the process. • Expresses the precision under the same operating
• Requires a knowledge of the process. conditions over a short interval of time.
• Having identified these features, an experimental • Minimum of 9 determinations covering the specified
design and sampling plan that captures the relevant range for the procedure
measurements is needed. • Minimum of 6 determinations at 100% of the test
• Each type of dosage form or product is different and concentration.
may require different considerations.
• Statistical analysis of the data is useful - should be INTERMEDIATE PRECISION
used to aid in an understanding of the data only.
• Hypothesis testing may not be useful - power • Expresses within-laboratories variations: different days,
considerations. different analysts, different equipment, etc.
• Scientific judgement
REPRODUCILIBILITY: • For the establishment of linearity, a minimum of 5
concentrations is recommended.
• Expresses the precision between laboratories. • Other approaches should be justified.
• Precision should be investigated using homogeneous,
authentic samples. RANGE
• The precision of an analytical procedure is usually
expressed as the variance, standard deviation or • Interval between the upper and lower concentration of
coefficient of variation (relative standard deviation) of a analyte in the sample
series of measurements. ROBUSTNESS
ASSAY VALIDATION
• Preparation of samples
• Analysis of samples
• Calculation of percent relative deviation
• Results should be accurate and precise • Calculation of percent relative error
• In a normal distribution, 68% of the values should fall • Disposition
within one standard deviation in either side of the mean • Documentation
• And 95% should fall within two standard deviations of
the mean A. PREPARATION OF SAMPLES
• So, standard deviation should be a small percentage of
the mean. Prepare a total of 6 validation samples (or 3 pairs for duplicate
determination) as follows:
B. ANALYSIS
• Two different analysts should carry out a single
Detection Limit (LOD) determination on each of the three drug levels by the
• Lowest amount of analyte in a sample which can be assay method prescribed for the product.
detected but not necessarily quantitated as an exact • The analysts should carry out the assay validation
value analysis on different days. Results of the analyses
should be reported as percent of formula quantity.
Quantitation Limit (LOQ)
C. CALCULATION
• Lowest amount of analyte in a sample which can be
• The percentage relative deviation (D) is a measure of
quantitatively determined with suitable precision and
the precision of the method.
accuracy.
• In using the formula, ignore the negative sign from
• Parameter of quantitative assays - low levels of
subtraction.
compounds in sample matrices
• The percentage relative error (E) is a measure of the
• determination of impurities and/or degradation
accuracy of the method.
products.
• The lower the values for % Relative Deviation and %
LINEARITY Relative Error, the better the method. All values of %
Relative Deviation (DA, DB, and Dc) and the % Relative
• The linearity of an analytical procedure is its ability Error (EA, EB, and EC) must be below an acceptable
(within a given range) to obtain test results which are limit.
directly proportional to the concentration (amount) of • It is difficult to set an acceptable limit for the required
analyte in the sample. accuracy and precision of a method, since there are
• If there is a linear relationship, test results should be variables that depend on the method being used and
evaluated by appropriate statistical methods, for the product being tested.
example, by calculation of a regression line by the • There is no substitute for knowledge of analytical
method of least squares. chemistry and good scientific judgment.
• The correlation coefficient, y-intercept, slope of the • Most modern analytical procedures should have an
regression line and residual sum of squares should be accuracy and precision in the range of 1 to 2 percent.
submitted. • If a value greater than 2.0 (ignoring the sign) is obtained
• A plot of the data should be included. In addition, an for (D) and (E) when the monograph limits are 90% and
analysis of the deviation of the actual data points from 110%, a problem with the assay method is indicated.
the regression line may also be helpful for evaluating • A value of 1.0% is used if the monograph limits are 95%
linearity. and 105%
D. DISPOSITION
• Unsatisfactory - subject the procedure to appropriate
RE-VALIDATION
review, designed-study, revision or replacement
• Satisfactory - assay method should be left alone • to ensure continuing validity of the cleaning
procedures.
E. DOCUMENTATION
• Written validation profile Some approaches to validation of cleaning procedures are:
Facility or equipment validation • which is based on the assumption that the active
ingredient is the most deleterious contaminant and that
• confirmation that the specified process conditions are the mix ratio of active to excipient is indicative of
reliably fulfilled in a given apparatus. excipient residue levels.
• Prioritization of product lines chosen for validation is
The validation program consists of several phases governed by toxicity of the active ingredient and/or
• installation qualification, operational qualification and frequency (volume) of production.
actual validation DETERGENT RESIDUE LEVELS
INSTALLATION QUALIFICATION
• which are assumed to be independent of the product
• must cover a number of items such as: and are validated by equipment piece and detergent
POST-VALIDATION
1. Utilities connection to determine if they comply to
regulatory requirements and all applicable corporate • Required whenever there is a change in formulation,
standards, processing conditions, analytical methods, cleaning
2. Equipment features and characteristics: description procedures or materials.
and specifications,
3. Sanitation program COMMON CATEGORIES OF TESTS
4. Maintenance and Drawing
CATEGORY I
OPERATION QUALIFICATION
• Analytical procedures for quantitation of major
• Obtain adequate assurance that the equipment when component of bulk drug substances or active
operated by the approved SOP’s does perform its ingredients in finished pharmaceutical products.
assigned limits.
CATEGORY II
1. Applicable SOP’s • Analytical procedures for determination of impurities in
2. Utilization list bulk drug substances or degradation compounds in
3. Process description finished pharmaceutical products.
4. Key process variables • Quantitative assays and limit tests.
5. Test functions – the items to be tested are indicated.
CATEGORY III
VALIDATION
• Analytical procedures for determination of
• consists of the following steps: performance characteristics
CLEANING VALIDATION
• Pre-validation
• Validation
• Re-validation
PRE-VALIDATION
VALIDATION
INSTRUMENTALMETHODS OF ANALYSIS
COLORIMETERS
TITRATIONS
CHEMICAL NOISE
INSTRUMENTAL NOISE